Moreover, it promotes bradykinin production which, though bradykinin receptor type 2 (BK2R), leads to NO formation and it can antagonize AT1R-mediated activation of MAP kinases, key regulators in several cell signaling pathways and is involved in vascular remodeling, renal fibrosis, and cardiac hypertrophy [41]. Here, AGTR1 is linked to cardiac hypertrophy.